Mineyoshi Sato is a Research Associate in the Merghoub-Wolchok Laboratory at Weill Cornell Medicine. Board-certified in respiratory medicine with a clinical subspecialty in thoracic oncology in Japan, he brings focused expertise in lung cancer to his laboratory-based research. His current work examines the tumor-immune microenvironment in KRAS-mutant lung cancer, with a particular focus on how combined targeted therapy and immunomodulatory agents reshape the immune landscape of the tumor.